Table 3.
Patient Number | Gender | Age (years) | Phenotype | Therapies | VA (first visit) | VA (after therapies) | ||
---|---|---|---|---|---|---|---|---|
OD | OS | OD | OS | |||||
5 | Female | 10 | ARB with OU CNV | OD IVB∗2 OS IVB∗1 |
0.05 | 0.6 | 0.2 | 0.63 |
7 | Female | 11 | ARB with OU retinoschisis | OU IVR∗1 | 0.5 | 0.5 | 0.5 | 0.63 |
11 | Female | 5 | ARB with OD CNV | - | 0.2 | 0.25 | - | - |
ARB: autosomal recessive bestrophinopathy. VA: visual acuity. OD: oculus dexter, right eye. OS: oculus sinister, left eye. OU: oculus uterque, binoculus. CNV: choroidal neovascularization. IVB: intravitreal injection of bevacizumab. IVR: intravitreal injection of ranibizumab. Asterisks mean times of therapy. Blank sections mean no data available.